Corrigendum: Isoliquiritigenin Protects Against Pancreatic Injury and Intestinal Dysfunction After Severe Acute Pancreatitis <i>via</i> Nrf2 Signaling.

Corrigendum: Isoliquiritigenin Protects Against Pancreatic Injury and Intestinal Dysfunction After Severe Acute Pancreatitis via Nrf2 Signaling.

Zhang, Man; Wu, Yan-Qing; Xie, Ling; Wu, Jiang; Xu, Ke; Xiao, Jian; Chen, Da-Qing.

Afiliação

Zhang M; Department of Emergency, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou Medical University, Wenzhou, China.
Wu YQ; Molecular Pharmacology Research Center, School of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, China.
Xie L; Molecular Pharmacology Research Center, School of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, China.
Wu J; Molecular Pharmacology Research Center, School of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, China.
Xu K; Wenzhou University College of Life and Environmental Science, Wenzhou, China.
Xiao J; Molecular Pharmacology Research Center, School of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, China.
Chen DQ; Department of Emergency, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou Medical University, Wenzhou, China.

Front Pharmacol ; 10: 788, 2019.

Article em En | MEDLINE | ID: mdl-31354498